The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Globe Investor

News Sources

Take control of your investments with the latest investing news and analysis

Press release from PR Newswire

Third Quarter 2011 Results Date Notification - October 28, 2011

Thursday, October 13, 2011

Third Quarter 2011 Results Date Notification - October 28, 201107:00 EDT Thursday, October 13, 2011DUBLIN, Ireland, October 13, 2011 /PRNewswire/ --Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce third quarter 2011 earnings on Friday October 28, 2011. Results press release will be issued at: 12:00 BST / 07:00 EDT Investor conference call time: 14:00 BST / 09:00 EDT Live conference call for investors:Angus Russell, Chief Executive Officer and Graham Hetherington, Chief Financial Officer will host the investor and analyst conference call at 14:00 BST/9:00 EDT.The details of the conference call are as follows:       UK dial in: 0800-077-8492 or 0844-335-0351     US dial in: 1-866-8048688 or 1-718-3541175     International dial in: +44-208-996-3900     Global Access Numbers: http://www.btconferencing.com/globalaccess/?bid=54_attended     Password/Conf ID: 280 117     Live Webcast: http://www.shire.com/shireplc/en/investorsReplay:A replay of the presentation will be available for two weeks by phone and by webcast for one year.  Details can be found on our Investor Relations website http://www.shire.com/shireplc/en/investors.Notes to editorsSHIRE PLCShire's strategic goal is to become the leading specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.  Shire focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine, as well as opportunities in other therapeutic areas to the extent they arise through acquisitions.  Shire's in-licensing, merger and acquisition efforts are focused on products in specialist markets with strong intellectual property protection and global rights.  Shire believes that a carefully selected and balanced portfolio of products with strategically aligned and relatively small-scale sales forces will deliver strong results.For further information on Shire, please visit the Company's website: http://www.shire.com.For further information please contact: Investor Relations Souheil Salah (ssalah@shire.com) +44-1256-894-160 Erin Kelly (erikelly@shire.com) +1-781-482-9541SOURCE Shire plcFor further information: .